ONCOLYTICS BIOTECH INC's ticker is ONCY and the CUSIP is 682310875. A total of 36 filers reported holding ONCOLYTICS BIOTECH INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,173 | -35.4% | 9,712 | -21.6% | 0.00% | – |
| Q2 2023 | $32,789 | -88.5% | 12,386 | -94.8% | 0.00% | -100.0% |
| Q1 2023 | $285,524 | +2096.3% | 238,082 | +2757.4% | 0.00% | – |
| Q4 2022 | $13,000 | +30.0% | 8,332 | +11.2% | 0.00% | – |
| Q3 2022 | $10,000 | +25.0% | 7,490 | 0.0% | 0.00% | – |
| Q2 2022 | $8,000 | -27.3% | 7,490 | -6.6% | 0.00% | – |
| Q1 2022 | $11,000 | +175.0% | 8,017 | +170.7% | 0.00% | – |
| Q4 2021 | $4,000 | -33.3% | 2,962 | 0.0% | 0.00% | – |
| Q3 2021 | $6,000 | -50.0% | 2,962 | -33.6% | 0.00% | – |
| Q2 2021 | $12,000 | -25.0% | 4,462 | +12.6% | 0.00% | – |
| Q1 2021 | $16,000 | +128.6% | 3,962 | +33.8% | 0.00% | – |
| Q4 2020 | $7,000 | +16.7% | 2,962 | -2.2% | 0.00% | – |
| Q3 2020 | $6,000 | 0.0% | 3,029 | 0.0% | 0.00% | – |
| Q2 2020 | $6,000 | -53.8% | 3,029 | -69.9% | 0.00% | – |
| Q1 2020 | $13,000 | – | 10,049 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynwood Capital Management Inc. | 25,000 | $41 | 0.05% |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | 183,783 | $299,566 | 0.03% |
| BRAVE ASSET MANAGEMENT INC | 20,000 | $32,772 | 0.01% |
| Newman Dignan & Sheerar, Inc. | 18,915 | $30,831 | 0.01% |
| Virtu Financial LLC | 24,953 | $41 | 0.01% |
| Long Focus Capital Management, LLC | 40,000 | $65,200 | 0.00% |
| Cedar Mountain Advisors, LLC | 5,651 | $9,211 | 0.00% |
| Banque Cantonale Vaudoise | 11,900 | $19 | 0.00% |
| SITTNER & NELSON, LLC | 1,000 | $1,639 | 0.00% |
| OSAIC HOLDINGS, INC. | 8,332 | $13,000 | 0.00% |